Abstract:Objective: Upper urinary tract urothelial carcinoma (UTUC) is a relatively uncommon disease with few reported molecular markers. This study evaluated Tim-3 and PD-1 expression in primary UTUC and its impact on patients' clinical outcomes. Methods: Tim-3 and PD-1 protein expression was detected by immunohistochemistry in paraffin-embedded sections from 101 UTUC patients. The H-score was correlated with clinicopathologic outcomes and the long-term recurrence and survival rates. Results: T cell immunoglobulin mucin-3 (Tim-3) protein was overexpressed in UTUC cells, especially tumour-infiltrating lymphocytes (TILs) and endothelial cells. We found that 95% (95/101) of UTUC tissues had dysregulated Tim-3 expression, of which 44% (44/101) showed high expression. High Tim-3 expression (H-score >= 100) was significantly correlated with advanced pathological grade, advanced T stage and tumour recurrence (P=0.016, 0.001 and < 0.001, respectively) and with poor intravesical recurrence-free survival (IRFS) and overall survival (OS) (P<0.001 and 0.003). Moreover, another immune checkpoint molecule, programmed death receptor-1 (PD-1), was also assessed in our study. Among patients in the low Tim-3 expression subgroup, those with high PD-1 expression experienced intravesical recurrence (IVR) more often than those with low PD-1 expression (P<0.001). However, the PD-1 expression level had no effect on prognosis in the high Tim-3 expression subgroup. Conclusion: We confirmed that high Tim-3 protein expression can be used as an indicator of earlier IVR and shorter OS in patients with UTUC, while high expression of PD-1 is only related to earlier IVR. We showed that Tim-3 plays a more important role in tumour recurrence and progression than PD-1. Collectively, our findings support the use of Tim-3 and PD-1 as clinical prognostic factors indicating poor patient survival. Tim-3, alone or in combination with PD-1, could become a target for future UTUC therapies, but further prospective studies are needed. (C) 2021 Elsevier Inc. All rights reserved.

The expression and clinical significance of UPⅢin cystitis glandularis

Study of the Expression of CK20 and Ki67 on Cystitis Glandularis of the Urinary Bladder

The expression and significance of CK20 and Ki67 of inverted papilloma of the urinary bladder

Inverted Papilloma of Urinary Bladder:A Clinicopathological Study of 60 Cases

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Uroplakin Ⅲ expression and primary vesicoureteric reflux

The Expression of Uroplakins in the Transitional Cell Carcinoma of Bladder

The Expression and Clinical Significance of PD-L1 in Patients with Upper Tract Urothelial Carcinoma.

Application of PDECGF/TP and VEGF in the Diagnosis of Interstitial Cystitis

Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues

Diagnosis and Treatment of Cystitis Glandularis: A Analysis of 211 Cases

The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma

Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study

Clinical analysis of cystitis glandularis combined with severe atypical hyperplasia (a report of 13 cases)

Correlation analysis of the expression intensity of novel gene UCA1 and tumor grade of urothelial carcinoma

Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis

UPK3A: a promising novel urinary marker for the detection of bladder cancer.

Diagnosis and Treatment of Cystitis Glandularis:a Report of 96 Cases

PD-L1 Expression Level in Chinese Upper Tract Urothelial Cancer (UTUC) Patients and Its Correlation with Pathological and Clinical Features.

The accuracy of ureteroscopic biopsy in the diagnosis of transitional cell cancer of upper urinary tract(report of 35 cases)

The expression of SP263 in muscle invasive bladder carcinoma and its relationship with clinicopathological features